1 |
BDKRB2
💬
| 10件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Endocrine and other factor-regulated calcium reabsorption, Chagas disease, Pathways in cancer | Deucrictibant
Deucrictibant
💬
|
Deucrictibant
| 1件: 65 65 💬
|
2 |
BDKRB2
💬
| 10件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Endocrine and other factor-regulated calcium reabsorption, Chagas disease, Pathways in cancer | Icatibant acetate
Icatibant acetate
💬
|
Icatibant
| 1件: 65 65 💬
|
3 |
C1R
💬
| 6件: Phagosome Phagosome, Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 2件: 61 61, 65 💬
|
4 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Riliprubart
Riliprubart
💬
|
Riliprubart
| 1件: 14 14 💬
|
5 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 2件: 61 61, 65 💬
|
6 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Sutimlimab
Sutimlimab
💬
|
Sutimlimab
| 1件: 61 61 💬
|
7 |
C2
💬
| 6件: Complement and coagulation cascades Complement and coagulation cascades, Alcoholic liver disease, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Empasiprubart
Empasiprubart
💬
|
Empasiprubart
| 2件: 14 14, 50 💬
|
8 |
C3
💬
| 17件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phagosome, Complement and coagulation cascades, Neutrophil extracellular trap formation, Alcoholic liver disease, Shigellosis, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, Staphylococcus aureus infection, Tuberculosis, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Viral carcinogenesis, Systemic lupus erythematosus | Pegcetacoplan
Pegcetacoplan
💬
|
Pegcetacoplan
| 4件: 2 2, 61, 62, 222 💬
|
9 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Zilucoplan sodium
Zilucoplan sodium
💬
|
Zilucoplan
| 2件: 11 11, 62 💬
|
10 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Gefurulimab
Gefurulimab
💬
|
Gefurulimab
| 1件: 11 11 💬
|
11 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Crovalimab
Crovalimab
💬
|
Crovalimab
| 2件: 62 62, 109 💬
|
12 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Nomacopan
Nomacopan
💬
|
Nomacopan
| 3件: 62 62, 109, 162 💬
|
13 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Eculizumab
Eculizumab
💬
|
Eculizumab
| 8件: 11 11, 13, 14, 61, 62, 109, 221, 222 💬
|
14 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Vilobelimab
Vilobelimab
💬
|
Vilobelimab
| 3件: 43 43, 44, 269 💬
|
15 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Ravulizumab
Ravulizumab
💬
|
Ravulizumab
| 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
16 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Pozelimab
Pozelimab
💬
|
Pozelimab
| 3件: 11 11, 15, 62 💬
|
17 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Avacincaptad pegol sodium
Avacincaptad pegol sodium
💬
|
Avacincaptad pegol
| 1件: 301 301 💬
|
18 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Zilucoplan
Zilucoplan
💬
|
Zilucoplan
| 2件: 11 11, 62 💬
|
19 |
C5AR1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Alcoholic liver disease, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Avacopan
Avacopan
💬
|
Avacopan
| 4件: 43 43, 44, 66, 222 💬
|
20 |
CFB
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Iptacopan hydrochloride
Iptacopan hydrochloride
💬
|
Iptacopan
| 6件: 11 11, 61, 62, 66, 109, 222 💬
|
21 |
CFB
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Iptacopan
Iptacopan
💬
|
Iptacopan
| 6件: 11 11, 61, 62, 66, 109, 222 💬
|
22 |
CFD
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Danicopan
Danicopan
💬
|
Danicopan
| 2件: 62 62, 222 💬
|
23 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Apixaban
Apixaban
💬
|
Apixaban
| 4件: 96 96, 97, 222, 279 💬
|
24 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Rivaroxaban
Rivaroxaban
💬
|
Rivaroxaban
| 6件: 46 46, 49, 56, 91, 210, 271 💬
|
25 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Edoxaban tosilate hydrate
Edoxaban tosilate hydrate
💬
|
Edoxaban
| 2件: 46 46, 88 💬
|
26 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Edoxaban
Edoxaban
💬
|
Edoxaban
| 2件: 46 46, 88 💬
|
27 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬
|
Emicizumab
| 1件: 288 288 💬
|
28 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Edoxaban tosylate
Edoxaban tosylate
💬
|
Edoxaban
| 2件: 46 46, 88 💬
|
29 |
F12
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Garadacimab
Garadacimab
💬
|
Garadacimab
| 1件: 65 65 💬
|
30 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Thrombomodulin alfa
Thrombomodulin alfa
💬
|
Thrombomodulin Alfa
| 1件: 85 85 💬
|
31 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Dabigatran etexilate
Dabigatran etexilate
💬
|
Dabigatran etexilate
| 2件: 51 51, 75 💬
|
32 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Dabigatran
Dabigatran
💬
|
Dabigatran
| 5件: 51 51, 75, 85, 91, 124 💬
|
33 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Dabigatran etexilate mesylate
Dabigatran etexilate mesylate
💬
|
Dabigatran etexilate
| 2件: 51 51, 75 💬
|
34 |
F7
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Eptacog alfa
Eptacog alfa
💬
|
Coagulation factor VIIa Recombinant Human
| 1件: 288 288 💬
|
35 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Susoctocog alfa
Susoctocog alfa
💬
|
Susoctocog alfa
| 1件: 288 288 💬
|
36 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Rurioctocog alfa pegol
Rurioctocog alfa pegol
💬
|
Rurioctocog alfa pegol
| 1件: 288 288 💬
|
37 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Efanesoctocog alfa
Efanesoctocog alfa
💬
|
Efanesoctocog alfa
| 1件: 288 288 💬
|
38 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Desmopressin
Desmopressin
💬
|
Desmopressin
| 6件: 6 6, 64, 72, 75, 225, 288 💬
|
39 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Octocog alfa
Octocog alfa
💬
|
Antihemophilic factor, human recombinant
| 1件: 288 288 💬
|
40 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Desmopressin acetate
Desmopressin acetate
💬
|
Desmopressin
| 6件: 6 6, 64, 72, 75, 225, 288 💬
|
41 |
F9
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬
|
Emicizumab
| 1件: 288 288 💬
|
42 |
KLKB1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Berotralstat hydrochloride
Berotralstat hydrochloride
💬
|
Berotralstat
| 1件: 65 65 💬
|
43 |
KLKB1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 2件: 61 61, 65 💬
|
44 |
KLKB1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Berotralstat
Berotralstat
💬
|
Berotralstat
| 1件: 65 65 💬
|
45 |
KLKB1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Ecallantide
Ecallantide
💬
|
Ecallantide
| 1件: 65 65 💬
|
46 |
KLKB1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Lanadelumab
Lanadelumab
💬
|
Lanadelumab
| 1件: 65 65 💬
|
47 |
KLKB1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Sebetralstat
Sebetralstat
💬
|
Sebetralstat
| 1件: 65 65 💬
|
48 |
MASP2
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Narsoplimab
Narsoplimab
💬
|
Narsoplimab
| 2件: 66 66, 222 💬
|
49 |
PLAT
💬
| 5件: Apelin signaling pathway Apelin signaling pathway, Complement and coagulation cascades, Transcriptional misregulation in cancer, Prostate cancer, Fluid shear stress and atherosclerosis | Aminocaproic acid
Aminocaproic acid
💬
|
Aminocaproic acid
| 1件: 70 70 💬
|
50 |
PLG
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A | Tranexamic acid
Tranexamic acid
💬
|
Tranexamic acid
| 8件: 46 46, 65, 70, 215, 227, 274, 288, 299 💬
|
51 |
PLG
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A | Aminocaproic acid
Aminocaproic acid
💬
|
Aminocaproic acid
| 1件: 70 70 💬
|
52 |
SERPINA1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | alpha 1-Antitrypsin
alpha 1-Antitrypsin
💬
|
Alpha-1-proteinase inhibitor
| 3件: 231 231, 298, 299 💬
|
53 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Heparin calcium
Heparin calcium
💬
|
Heparin
| 10件: 47 47, 60, 65, 70, 79, 84, 107, 226, 280, 299 💬
|
54 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Adomiparin
Adomiparin
💬
|
Enoxaparin
| 1件: 46 46 💬
|
55 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Enoxaparin sodium
Enoxaparin sodium
💬
|
Enoxaparin
| 1件: 46 46 💬
|
56 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Dalteparin sodium
Dalteparin sodium
💬
|
Dalteparin
| 1件: 222 222 💬
|
57 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Heparin sodium
Heparin sodium
💬
|
Heparin
| 10件: 47 47, 60, 65, 70, 79, 84, 107, 226, 280, 299 💬
|
58 |
VWF
💬
| 8件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Complement and coagulation cascades, Platelet activation, Neutrophil extracellular trap formation, Human papillomavirus infection, Coronavirus disease - COVID-19 | Caplacizumab
Caplacizumab
💬
|
Caplacizumab
| 2件: 63 63, 64 💬
|